bioMérieux has acquired Neoprospecta, a Brazil-based developer of data and genomics solutions for food industry quality assurance programs and microbiological risk prevention.

Founded in 2011, biotechnical company Neoprospecta is dedicated to the development and commercialization of innovative microbiological analysis, based on next-generation DNA sequencing and biocomputational analysis. Among the various technologies and services in its portfolio, Neoprospecta’s Neobiome is a strategic tool for decision-making based on microbiome information. The data and genomics analysis platform enables food industry players to enhance the quality and safety of their production by helping track and control areas of contamination, assess and manage risk, improve processes, and define good practices for microbiological control.

With its acquisition of Neoprospecta, bioMérieux is strengthening its Data and Genomics offering, which comprises innovative pathogen and spoiler investigation tools to prevent contamination, reinforcing the company’s Augmented Diagnostics approach. The initial phase of the acquisition will expand data and genomics capabilities in Brazil and Latin America. Next, bioMérieux will gradually integrate Neoprospecta technologies into its unique portfolio and make them available in selected markets across the world.

Under the terms of the sale and purchase agreement, bioMérieux will acquire 100 percent ownership of Neoprospecta for an undisclosed amount. The transaction is expected to close in the coming months, once customary closing conditions have been met.